Phase 1 Basal Cell Carcinoma Clinical Trials
8 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+10 more
National Cancer Institute (NCI)16 enrolled26 locationsNCT05896839
Recruiting
Phase 1Phase 2
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
CancerMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc.90 enrolled28 locationsNCT04349436
Recruiting
Phase 1
Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
Basal Cell Carcinoma (BCC)
Nathalie Zeitouni20 enrolled1 locationNCT06623201
Recruiting
Phase 1
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
MelanomaHead and Neck Squamous Cell CarcinomaMetastatic Cancer+16 more
Memorial Sloan Kettering Cancer Center56 enrolled7 locationsNCT05859074
Recruiting
Phase 1Phase 2
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Cutaneous Basal Cell Carcinoma
Instituto Oncológico Dr Rosell18 enrolled4 locationsNCT07251413
Recruiting
Phase 1Phase 2
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
Skin CancerSquamous Cell CarcinomaBasal Cell Carcinomas+1 more
Bruce Robinson, MD100 enrolled1 locationNCT07010692
Recruiting
Phase 1Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
MediWound Ltd32 enrolled3 locationsNCT05157763